Plunkett Research Online: Innovate

INNOVATE (INNT:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Innovate Biopharmaceuticals Inc is a clinical stage biotechnology company. The company is engaged in developing novel medicines for an autoimmune/ inflammatory disease. It includes drug candidates for celiac disease, NASH, Crohn's, and ulcerative colitis......



Innovate
Ticker: INNT
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 919 275-1933
Fax:
Address: 8480 Honeycutt Road
Suite 120
Raleigh, NC 27615 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Vaccines, Skin Replacement Products and Biologicals Manufacturing
ContactsDescription
Sandeep LaumasCEO/Chairman of the Board/Director
June AlmenoffChief Medical Officer/COO
See More
Innovate Biopharmaceuticals Inc is a clinical stage biotechnology company. The company is engaged in developing novel medicines for an autoimmune/ inflammatory disease. It includes drug candidates for celiac disease, NASH, Crohn's, and ulcerative colitis......See More See More

Auditor: Mayer Hoffman McCann P.C.
Legal Advisor:
$USD, In whole numbers,
except marked * or %
20172016201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: